Igenomix

Unclaimed

Nano-influencer • Spain • EN

Igenomix is a medical testing laboratory specializing in reproductive genetic services. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive. In 2021, Vitrolife acquired Igenomix, founded in 2011. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our vision is to enable people to fulfill the dream of having a healthy baby. Our mission is to be the leading global partner in reproductive health, striving for better treatment outcomes for patients. Together we create excellence in reproductive health. The Vitrolife AB (publ) share is listed on Nasdaq Stockholm.

Wellness

Apply to work together Is this you? Claim profile

Combined followers

4.6K

Engagement rate

1.3%

Estimated reach / post

Audience auth score

100/100

Platforms

YouTube

About Igenomix

Igenomix is a nano wellness content creator based in Spain. Across 1 platform their combined audience is 4.6K, with an average engagement rate of 1.3% and an audience authenticity score of 100 out of 100.

Frequently asked

What is Igenomix's engagement rate?: 1.3% on average across their active platforms. That is below typical benchmark for the nano tier.
How many followers does Igenomix have?: 4.6K combined, with 4.6K on YouTube.
Does Igenomix accept gifted products or hosted stays?: Gifted product: no. Hosted stays: no.
Is Igenomix verified on Ikaroa Amplify?: Not yet. The data on this page comes from public engagement signals. The creator can claim the profile to unlock brand messaging.

Are you Igenomix? Claim this profile in two minutes to manage your rate card and receive paid, gifted, and hosted offers.